Apnimed has announced The Lancet has published positive results from the Phase 2 FLOW study evaluating sulthiame, a differentiated, once-daily oral carbonic anhydrase inhibitor, in the treatment of ...

A comprehensive review published today in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical ...

Moderate-to-severe obstructive sleep apnea is linked to a doubling in 8-year risk for cerebral microbleeds in middle-aged and ...

Dr. Meena Khan with the Ohio State University Wexner Medical Center says there are several ways to treat obstructive sleep ...

A new guideline published by the American Academy of Sleep Medicine in the Journal of Clinical Sleep Medicine is the first to provide recommendations for the management of obstructive sleep apnea in ...

Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...

Nyxoah to Participate in the Stifel 2025 Healthcare Conference Mont-Saint-Guibert, Belgium – November 3, 10:05pm CET / 4:05pm ET – Nyxoah SA ...

Dr. Fred Shield is joining Union Health as a specialist in Internal Medicine. Dr. Shield specializes in the treatment of ...

The maker of devices for treating obstructive sleep apnea posted revenue of $224.5 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $220.9 million.

The Food and Drug Administration has approved a GLP-1 agonist for treating sleep apnea. Here’s how it works and what you can ...

Foldvary recommends several evidence-based habits for better sleep. Avoid eating or exercising right before bedtime, as both ...